Stockreport

Unicycive Therapeutics to Participate in Upcoming Investor Events in December

Unicycive Therapeutics, Inc.  (UNCY) 
PDF LOS ALTOS, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patie [Read more]